Gideon St Helen1,2,3, Christopher Havel1, Delia A Dempsey1, Peyton Jacob1,2,3, Neal L Benowitz1,2,3,4. 1. Division of Clinical Pharmacology and Experimental Therapeutics, Department of Medicine, University of California, San Francisco, CA, USA. 2. Center for Tobacco Control Research and Education, University of California, San Francisco, CA, USA. 3. Tobacco Center of Regulatory Science, University of California, San Francisco, CA, USA. 4. Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA.
Abstract
AIMS: To measure the systemic retention of nicotine, propylene glycol (PG) and vegetable glycerin (VG) in electronic cigarette (e-cigarette) users, and assess the abuse liability of e-cigarettes by characterizing nicotine pharmacokinetics. DESIGN: E-cigarette users recruited over the internet participated in a 1-day research ward study. Subjects took 15 puffs from their usual brand of e-cigarette. Exhaled breath was trapped in gas-washing bottles and blood was sampled before and several times after use. SETTING: San Francisco, California, USA. PARTICIPANTS: Thirteen healthy, experienced adult e-cigarette users (six females and seven males). MEASUREMENTS: Plasma nicotine was analyzed by gas chromatography-mass spectrometry (GC-MS/MS) and nicotine, VG and PG in e-liquids and gas traps were analyzed by LC-MS/MS. Heart rate changes and subjective effects were assessed. FINDINGS: E-cigarettes delivered an average of 1.33 (0.87-1.79) mg [mean and 95% confidence interval (CI)] of nicotine, and 93.8% of the inhaled dose, 1.22 (0.80-1.66) was systemically retained. Average maximum plasma nicotine concentration (Cmax ) was 8.4 (5.4-11.5) ng/ml and time of maximal concentration (Tmax ) was 2-5 minutes. One participant had Tmax of 30 minutes. 84.4% and 91.7% of VG and PG, respectively, was systemically retained. Heart rate increased by an average of 8.0 beats per minute after 5 minutes. Withdrawal and urge to smoke decreased and the e-cigarettes were described as satisfying. CONCLUSIONS: E-cigarettes can deliver levels of nicotine that are comparable to or higher than typical tobacco cigarettes, with similar systemic retention. Although the average maximum plasma nicotine concentration in experienced e-cigarette users appears to be generally lower than what has been reported from tobacco cigarette use, the shape of the pharmacokinetic curve is similar, suggesting addictive potential.
AIMS: To measure the systemic retention of nicotine, propylene glycol (PG) and vegetable glycerin (VG) in electronic cigarette (e-cigarette) users, and assess the abuse liability of e-cigarettes by characterizing nicotine pharmacokinetics. DESIGN: E-cigarette users recruited over the internet participated in a 1-day research ward study. Subjects took 15 puffs from their usual brand of e-cigarette. Exhaled breath was trapped in gas-washing bottles and blood was sampled before and several times after use. SETTING: San Francisco, California, USA. PARTICIPANTS: Thirteen healthy, experienced adult e-cigarette users (six females and seven males). MEASUREMENTS: Plasma nicotine was analyzed by gas chromatography-mass spectrometry (GC-MS/MS) and nicotine, VG and PG in e-liquids and gas traps were analyzed by LC-MS/MS. Heart rate changes and subjective effects were assessed. FINDINGS: E-cigarettes delivered an average of 1.33 (0.87-1.79) mg [mean and 95% confidence interval (CI)] of nicotine, and 93.8% of the inhaled dose, 1.22 (0.80-1.66) was systemically retained. Average maximum plasma nicotine concentration (Cmax ) was 8.4 (5.4-11.5) ng/ml and time of maximal concentration (Tmax ) was 2-5 minutes. One participant had Tmax of 30 minutes. 84.4% and 91.7% of VG and PG, respectively, was systemically retained. Heart rate increased by an average of 8.0 beats per minute after 5 minutes. Withdrawal and urge to smoke decreased and the e-cigarettes were described as satisfying. CONCLUSIONS: E-cigarettes can deliver levels of nicotine that are comparable to or higher than typical tobacco cigarettes, with similar systemic retention. Although the average maximum plasma nicotine concentration in experienced e-cigarette users appears to be generally lower than what has been reported from tobacco cigarette use, the shape of the pharmacokinetic curve is similar, suggesting addictive potential.
Authors: Marc S Berridge; Scott M Apana; Kenichi K Nagano; Catherine E Berridge; Gregory P Leisure; Mark V Boswell Journal: Psychopharmacology (Berl) Date: 2010-03-16 Impact factor: 4.530
Authors: Jill M Williams; Kunal K Gandhi; Shou-En Lu; Supriya Kumar; Junwu Shen; Jonathan Foulds; Howard Kipen; Neal L Benowitz Journal: Nicotine Tob Res Date: 2010-06-28 Impact factor: 4.244
Authors: Montse Ballbè; Jose M Martínez-Sánchez; Xisca Sureda; Marcela Fu; Raúl Pérez-Ortuño; José A Pascual; Esteve Saltó; Esteve Fernández Journal: Environ Res Date: 2014-09-27 Impact factor: 6.498
Authors: Tory R Spindle; Alison B Breland; Nareg V Karaoghlanian; Alan L Shihadeh; Thomas Eissenberg Journal: Nicotine Tob Res Date: 2014-09-19 Impact factor: 4.244
Authors: Wolfgang Schober; Katalin Szendrei; Wolfgang Matzen; Helga Osiander-Fuchs; Dieter Heitmann; Thomas Schettgen; Rudolf A Jörres; Hermann Fromme Journal: Int J Hyg Environ Health Date: 2013-12-06 Impact factor: 5.840
Authors: Peter Hajek; Maciej L Goniewicz; Anna Phillips; Katie Myers Smith; Oliver West; Hayden McRobbie Journal: Nicotine Tob Res Date: 2014-08-13 Impact factor: 4.244
Authors: Jonna M Leyrer-Jackson; Jose A Piña; Joseph McCallum; M Foster Olive; Cassandra D Gipson Journal: Brain Struct Funct Date: 2020-06-26 Impact factor: 3.270
Authors: Victor M Cardenas; Victoria L Evans; Appathurai Balamurugan; Mohammed F Faramawi; Robert R Delongchamp; J Gary Wheeler Journal: Int J Public Health Date: 2016-02-01 Impact factor: 3.380
Authors: Gideon St Helen; Delia A Dempsey; Christopher M Havel; Peyton Jacob; Neal L Benowitz Journal: Drug Alcohol Depend Date: 2017-06-30 Impact factor: 4.492
Authors: Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-05-18 Impact factor: 5.464
Authors: Mignonne C Guy; Jacob Helt; Sherilyn Palafox; Kellie Green; Eric K Soule; Sarah F Maloney; Thomas Eissenberg; Pebbles Fagan Journal: Nicotine Tob Res Date: 2019-09-19 Impact factor: 4.244